Pharming announces positive interim analysis data from open-la...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LEIDEN, Netherlands, Dec. 15, 2022 /PRNewswire-AsiaNet/ -- V. Koneti Rao, MD, shared new evidence of long-term safety and hematologic response in patients who received leniolisib to treat APDS, a rare primary immunodeficiencyInterim analysis demonstrated leniolisib to be well tolerated and indicated t...
Authors: LATEST ASIANET NEWS RELEASES